Al Jazeera examines HIV in Russia

Al Jazeera continues its coverage of HIV in Russia, where "[t]he latest official figures show that about 200 new cases are being recorded every single day." The news service writes, "HIV is spreading five times faster in Russia than the global average, with Ukraine and Russia accounting for 90 percent of the region's cases," adding, "The main source for 60 percent of new infections is dirty needles used to inject drugs." However, the country has "resisted so-called harm reduction strategies including funding needle exchange programs, angering health workers and global HIV prevention groups," Al Jazeera writes, noting, "Activists say social stigma is impeding the fight against HIV in Russia." An accompanying "Inside Story" video report examines how Russia "plan[s] to stem the rise in HIV" (1/4).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug